当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 资产负债表

翰宇药业

(300199)

  

流通市值:82.52亿  总市值:109.43亿
流通股本:6.66亿   总股本:8.83亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金51,454,083.5290,039,488.3483,507,809.83106,262,995.59
应收票据及应收账款276,047,552.81321,341,250.85322,218,741.83315,362,358.78
其中:应收票据-3,949,760.451,007,6404,323,040.03
应收账款276,047,552.81317,391,490.4321,211,101.83311,039,318.75
应收款项融资1,286,855.65,376,585.563,785,222.52,704,520.63
预付款项12,579,998.0621,757,044.169,127,778.511,960,008.82
其他应收款合计11,828,476.7814,877,035.2813,691,621.5311,882,576.66
存货200,221,673.73208,053,601.65208,673,602.27189,958,503.54
其他流动资产7,992,143.63,862,158.0911,079,626.513,624,279.7
流动资产平衡项目0000
流动资产合计561,410,784.1707,140,950.43796,359,733.06812,324,506.42
非流动资产:
其他权益工具投资5,736,507.475,736,507.475,736,507.475,736,507.47
其他非流动金融资产28,674,240.1628,857,952.1127,443,769.4827,814,787.77
投资性房地产215,625,187.34197,072,065.44197,509,508.99153,349,432.68
固定资产1,659,832,140.841,698,961,206.661,722,877,765.681,784,954,911.46
在建工程158,257,644.92159,564,786.76160,589,537.38153,994,880.06
使用权资产3,505,915.135,254,617.34959,197.982,877,593.94
无形资产252,314,035.1250,519,982.99257,315,261.43265,046,351.12
开发支出252,539,003.13262,973,716.74243,290,149.63242,257,925.03
长期待摊费用9,802,389.257,398,336.417,339,594.588,149,859.56
递延所得税资产39,270,158.4439,436,035.4839,895,508.6438,011,778.34
其他非流动资产104,465,910.93132,480,983.41122,361,740.92116,714,713.77
非流动资产平衡项目0000
非流动资产合计2,730,023,132.712,788,256,190.812,785,318,542.182,798,908,741.2
资产平衡项目0000
资产总计3,291,433,916.813,495,397,141.243,581,678,275.243,611,233,247.62
流动负债:
短期借款308,634,132.51307,450,560.95353,271,935.95315,922,501.59
应付票据及应付账款107,548,745.69123,236,375.57127,738,543.11129,054,453.09
应付账款107,548,745.69123,236,375.57127,738,543.11129,054,453.09
预收款项3,522,597.12,983,904.923,413,953.673,400,435.96
合同负债46,703,420.8257,694,800.5554,622,364.0562,687,751.68
应付职工薪酬13,145,946.7626,961,591.8719,565,589.4428,417,527.87
应交税费9,132,718.0616,276,972.339,128,793.6221,187,291
其他应付款合计78,481,544.284,089,053.7776,049,044.45122,137,658.51
一年内到期的非流动负债662,831,708.98759,694,715.24631,767,405.56458,991,408.69
其他流动负债5,639,516.986,676,010.246,628,783.866,157,725.58
流动负债平衡项目0000
流动负债合计1,235,640,331.11,385,063,985.441,282,186,413.711,147,956,753.97
非流动负债:
长期借款767,791,270.49680,730,382.49830,169,491.491,022,954,083.94
长期应付款3,500,0003,500,0003,500,0003,500,000
预计负债17,513,303.9817,513,303.9817,059,830.5117,059,830.51
递延收益113,619,102.4117,610,460.4118,400,943.97118,619,809.9
递延所得税负债4,201,121.624,788,071.884,201,121.624,201,121.62
非流动负债平衡项目0000
非流动负债合计906,624,798.49824,142,218.75973,331,387.591,166,334,845.97
负债平衡项目0000
负债合计2,142,265,129.592,209,206,204.192,255,517,801.32,314,291,599.94
所有者权益(或股东权益):
实收资本(或股本)883,241,336883,241,336883,241,336916,927,040
资本公积1,494,366,517.711,483,980,638.321,475,395,565.091,748,188,483.2
减:库存股---318,662,650.99
其他综合收益40,675,890.8541,245,845.9336,267,537.5737,498,076.66
盈余公积56,688,751.5656,688,751.5656,688,751.5656,688,751.56
未分配利润-1,350,552,354.98-1,204,136,694.87-1,151,397,416.3-1,170,002,990.99
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,124,420,141.141,261,019,876.941,300,195,773.921,270,636,709.44
少数股东权益24,748,646.0825,171,060.1125,964,700.0226,304,938.24
股东权益平衡项目0000
股东权益合计1,149,168,787.221,286,190,937.051,326,160,473.941,296,941,647.68
负债和股东权益合计3,291,433,916.813,495,397,141.243,581,678,275.243,611,233,247.62
公告日期2023-10-302023-08-152023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑